Skip to content

Author

Sherouk S Shams

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Sulforaphane mitigates behavioral deficits in experimental chronic kidney disease through regulation of Nrf2/NLRP3 inflammasome.

Sulforaphane dose-dependently improved renal function, histopathological alterations, behavioral performance, and brain antioxidant and anti-inflammatory status and may be associated with modulation of the Nrf2/NLRP3 signaling pathway.

Hend S Zakaria, M. T. Ghoneim, Doaa A. Ghareeb et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.